Positive inotropic effects of phenylephrine in the isolated rabbit papillary muscle mediated both by alpha- and beta-adrenoceptors.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D003864:Depression, Chemical; D004837:Epinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D008729:Methoxamine / Q000494:pharmacology; D009132:Muscles / Q000187:drug effects*; D009278:Naphazoline / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010109:Oxymetazoline / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010210:Papillary Muscles / Q000187:drug effects; D010646:Phentolamine / Q000494:pharmacology; D010656:Phenylephrine / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology*; D010726:Phosphodiesterase Inhibitors; D010869:Pindolol / Q000494:pharmacology; D011817:Rabbits; D011941:Receptors, Adrenergic; D012110:Reserpine / Q000494:pharmacology; D013268:Stimulation, Chemical; D013806:Theophylline / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D010726:Phosphodiesterase Inhibitors; D011941:Receptors, Adrenergic; D010656:Phenylephrine; D012110:Reserpine; D010109:Oxymetazoline; D010869:Pindolol; D013806:Theophylline; D010208:Papaverine; D009278:Naphazoline; D008729:Methoxamine; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine